Masimo (MASI) Competitors

IDEXX Laboratories (NASDAQ:IDXX) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership, dividends and community ranking.

Does the MarketBeat Community favor IDXX or MASI?

IDEXX Laboratories received 72 more outperform votes than Masimo when rated by MarketBeat users. Likewise, 72.36% of users gave IDEXX Laboratories an outperform vote while only 63.99% of users gave Masimo an outperform vote.

Company	Underperform	Outperform
IDEXX Laboratories	Outperform Votes 534 72.36%	Underperform Votes 204 27.64%
Masimo	Outperform Votes 462 63.99%	Underperform Votes 260 36.01%

Do institutionals and insiders believe in IDXX or MASI?

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 2.1% of IDEXX Laboratories shares are owned by insiders. Comparatively, 9.7% of Masimo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Do analysts recommend IDXX or MASI?

IDEXX Laboratories presently has a consensus price target of $539.63, suggesting a potential upside of 30.61%. Masimo has a consensus price target of $175.67, suggesting a potential upside of 4.87%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.90
Masimo	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Is IDXX or MASI more profitable?

IDEXX Laboratories has a net margin of 22.53% compared to Masimo's net margin of 3.85%. IDEXX Laboratories' return on equity of 55.42% beat Masimo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	22.53%	55.42%	25.90%
Masimo	3.85%	14.98%	6.95%

Which has preferable earnings & valuation, IDXX or MASI?

IDEXX Laboratories has higher revenue and earnings than Masimo. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$3.84B	8.80	$845.04M	$10.37	39.84
Masimo	$2.05B	4.38	$81.50M	$1.45	115.52

Does the media favor IDXX or MASI?

In the previous week, IDEXX Laboratories had 1 more articles in the media than Masimo. MarketBeat recorded 8 mentions for IDEXX Laboratories and 7 mentions for Masimo. Masimo's average media sentiment score of 0.95 beat IDEXX Laboratories' score of 0.13 indicating that Masimo is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Masimo	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, IDXX or MASI?

IDEXX Laboratories has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, Masimo has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Summary

IDEXX Laboratories beats Masimo on 16 of the 19 factors compared between the two stocks.